Key facts
- It has raised $1.3M; the latest was Debt - General ($440K) in Apr 2025.
- Notable investors include InnoFounder, Alexander Foss' Industrial Fund, BETA.HEALTH, Designcapital, Femovate — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Cacto Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Cacto Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cacto Health
Developer of a medical device system designed for monitoring lymphedema in breast cancer patients. The company's device focuses on early detection, home-monitoring, digitalization, and reliable self-performed measurements, utilizing principles of clinical expertise, enabling patients to actively manage their condition with accurate tools and fostering user-centered development practices.
- Sector
- Healthcare
- HQ
- Horsens, Denmark
- Founded
- 2022
- Employees
- 4
- Ownership
- Privately Held (backing)
Cacto Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cacto Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cacto Health in its N-PORT filings yet. We sweep new filings monthly.